US2002015744A1PendingUtilityA1
Combination of ginseng and ginkgo to improve cognitive skills
Priority: Dec 17, 1999Filed: Dec 18, 2000Published: Feb 7, 2002
Est. expiryDec 17, 2019(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/00A61P 25/28A61K 36/258A61K 36/16
32
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A dietary supplement consisting essentially of a combination of Ginseng and Ginkgo to improve the speed of memory and memory quality in normal, healthy subjects and to prevent deterioration of the speed of memory in people with decreased cognitive functions, and to counteract cognitive fatigue.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method to improve the speed of memory and memory quality in a normal, healthy person by co-administration of or a combination-administration of:
(i) the plant Panax ginseng , extracts thereof and/or the principal active substances thereof; and (ii) the plant Ginkgo biloba , extracts thereof and/or the principal active substances thereof.
2 . A method to prevent deterioration of the speed of memory in people with decreased cognitive functions by co-administration of or a combination-administration of:
(i) the plant Panax ginseng , extracts thereof and/or the principal active substances thereof; and (ii) the plant Ginkgo biloba , extracts thereof and/or the principal active substances thereof.
3 . A method to counteract cognitive fatigue by co-administration of or a combination-administration of:
(i) the plant Panax ginseng , extracts thereof and/or the principal active substances thereof; and (ii) the plant Ginkgo biloba , extracts thereof and/or the principal active substances thereof.
4 . A method for the enhancement of mental effort and/or cognitive performance comprising co-administration of synergistically enhancing amounts of:
(i) the plant Panax ginseng , extracts thereof and/or the principal active substances thereof; and (ii) the plant Ginkgo biloba , extracts thereof and/or the principal active substances thereof; to a person in acute need of such treatment.
5 . A method according to claim 4 wherein 200 to 1000 mg of a composition comprising
(i) about 100 parts per weight of an extract of the plant Panax ginseng ; and
(ii) about 60 parts per weight of an extract of the plant Ginkgo biloba , are co-administered 0.5 to 6.0 hours before said person is in need of such treatment.
6 . A method according to claim 1 wherein the components (i) and (ii) are administered orally.
7 . A method according to claim 1 wherein the Panax ginseng extract consists of at least 3% ginsenosides and the Ginkgo biloba extract consists of at least 20% ginkgo flavone glycosides and 2 to 10% terpene lactones.
8 . A method according to claim 4 wherein the components (i) and (ii) administered orally.
9 . A method according to claim 4 wherein the Panax ginseng extract consists of at least 3% ginsenosides and the Ginkgo biloba extract consists of at least 20% ginkgo flavone glycosides and 2 to 10% terpene lactones.Join the waitlist — get patent alerts
Track US2002015744A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.